跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 169 条关于
“Osteogenesis imperfecta”
全部
169
临床试验
118
药物
8
机构
0
资讯
43
去年
Ultragenyx's Setrusumab Receives FDA Breakthrough Therapy Designation for Osteogenesis Imperfecta
2年前
Setrusumab Shows Sustained Fracture Reduction in Osteogenesis Imperfecta Patients
去年
NextCure's NC605 Shows Promise in Treating Osteogenesis Imperfecta with Enhanced Bone Quality
10个月前
Stem Cell Therapy Shows 78% Fracture Reduction in Children with Osteogenesis Imperfecta
9个月前
FDA Grants Medivir's MIV-711 Orphan Drug Designation for Osteogenesis Imperfecta Treatment
8个月前
Setrusumab Phase 3 Trials in Osteogenesis Imperfecta Show Mixed Results Across Age Groups
10个月前
BOOST Pharma Secures €3.1 Million to Advance Stem Cell Therapy for Osteogenesis Imperfecta
去年
NextCure's Anti-Siglec-15 Antibody NC605 Shows Promise for Osteogenesis Imperfecta Treatment in Preclinical Study
去年
Ultragenyx and Mereo BioPharma Advance Setrusumab Phase 3 Studies for Osteogenesis Imperfecta Toward Year-End Analysis
10个月前
BOOST Pharma Advances Stem Cell Therapy BT-101 for Osteogenesis Imperfecta with Positive Two-Year Data and $4.4M Funding
第 1 页,共 5 页
上一页
下一页